LoneStar Heart Lands $20,000,000 New Round

  • Feed Type
  • Date
    10/10/2012
  • Company Name
    LoneStar Heart
  • Mailing Address
    26051 Merit Circle Laguna Hills, CA 92653
  • Company Description
    LoneStar Heart, Inc. is a Texas and California based biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF).
  • Website
    http://www.lonestarheartinc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $20,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    LoneStar Heart Inc. today announced the completion of an up to $20 million milestone-based equity financing to support the clinical testing andregulatory clearance of its lead product, Algisyl-LVR, a single-use, self-gelling biopolymerimplanted into the heart’s left ventricle during surgery for the treatment of advanced heart failure.
  • M&A Terms
  • Venture Investor
    Themes Investment Partners
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.